Work

A single-arm, phase II study of autophagy modulation using hydroxychloroquine in addition to encorafenib and cetuximab or panitumumab in metastatic BRAF-mutated colorectal cancer refractory to standard therapy.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.4_suppl.tps262

Authors: Chetan Vakkalagadda, Sabeeha Mukit, Masha Kocherginsky, Sheetal Mehta Kircher, Aparna Kalyan, Mary Frances Mulcahy, Al Bowen Benson, Navdeep Chandel, Devalingam Mahalingam

Institutions: Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4317863069

Cites:

Cited by:

Related to: 10